Pfizer Terminates Biometrics Services Contract With India’s Siro Clinpharm
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Pfizer has terminated its clinical data management and biometrics services contract with India's Siro Clinpharm as part of its "global strategy to reduce the number of biometric suppliers." Siro Clinpharm is one of the largest and most established players in the Indian clinical research industry